Drugs Made Financials
| DMII Stock | 9.93 0.01 0.10% |
Drugs Made Balance Sheet Chart
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Return On Equity | 1.04 | 1.17 |
|
| |||||
| Current Ratio | 0.18 | 0.21 |
|
|
Understanding current and past Drugs Made Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Drugs Made's financial statements are interrelated, with each one affecting the others. For example, an increase in Drugs Made's assets may result in an increase in income on the income statement.
Drugs Made Stock Summary
Drugs Made competes with Tower Semiconductor, Smith Micro, Coca Cola, and Constellation Software. Drugs Made is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Financial Services, Financial Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | KYG2851K1040 |
| Business Address | 1 East Broward |
| Sector | Capital Markets |
| Industry | Financials |
| Benchmark | Dow Jones Industrial |
| Phone | 954 870 3099 |
About Drugs Made Financials
What exactly are Drugs Made Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Drugs Made's income statement, its balance sheet, and the statement of cash flows. Potential Drugs Made investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Drugs Made investors may use each financial statement separately, they are all related. The changes in Drugs Made's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Drugs Made's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Drugs Made January 14, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Drugs Made help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Drugs Made In. We use our internally-developed statistical techniques to arrive at the intrinsic value of Drugs Made In based on widely used predictive technical indicators. In general, we focus on analyzing Drugs Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Drugs Made's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.1932 | |||
| Information Ratio | (0.48) | |||
| Maximum Drawdown | 0.9098 | |||
| Value At Risk | (0.10) | |||
| Potential Upside | 0.3036 |
Complementary Tools for Drugs Stock analysis
When running Drugs Made's price analysis, check to measure Drugs Made's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Drugs Made is operating at the current time. Most of Drugs Made's value examination focuses on studying past and present price action to predict the probability of Drugs Made's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Drugs Made's price. Additionally, you may evaluate how the addition of Drugs Made to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |